CNS Field means the field of prevention, palliation, control or treatment in humans of (a) depression, schizophrenia, bipolar disease, dementia, anxiety, attention deficit hyperactivity disorder, anorexia nervosa and other affective disorders, (b) Alzheimer’s disease and other cognitive disorders, (c) Pxxxxxxxx’x disease, amyotrophic lateral sclerosis and other neurodegenerative disorders, (d) pain, (e) epilepsy, (f) insomnia, narcolepsy and other sleep disorders, (g) substance abuse and (h) migraine.
CNS Field means the treatment or prevention of CNS diseases or disorders in humans.
CNS Field means use in the following indications: [***], in each case in humans, using any delivery modality.
Examples of CNS Field in a sentence
The covenant in Section 2.3 does not include any waiver of accruing liability in the CNS Field.
More Definitions of CNS Field
CNS Field means [***].
CNS Field means delivery of drugs for the treatment of --------- pain, [* * *] directly into a component of the central nervous system from an implantable pump via a catheter; provided, however, solely with respect to a Product using Sufentanil as the Drug, there shall be no requirement that the Drug be delivered via a catheter.
CNS Field means only the functionality within the applicable product that conforms to or practices all or any part of the Legacy Wi-Fi Standard. For clarity, CNS Field excludes the functionality within the applicable product that conforms to or practices all or any part of the Wi-Fi 6 Standard and/or any other IEEE 802.11 standard published thereafter.
CNS Field means diseases of the central nervous system.
CNS Field means the Exploitation of therapeutic compounds to treat, ameliorate or prevent CNS Diseases (and Diagnostics to the extent intended for use in connection with such therapeutic compounds).
CNS Field means the central nervous system (“CNS”) and/or cerebrocardiovascular drug application, including the (preventive) treatment of peripheral of effects of agents causing CNS disease or symptoms.
CNS Field means (a) the field of CNS Monogenic Rare Disorders, (b) Alzheimer’s Disease and Temporal Lobe Epilepsy, and (c) any other available non-monogenic and/or non-rare CNS indications that the Parties may mutually agree to include in the CNS Field [*] (the disorders under subsections